|
|
Clinical Investigation on Visual Quality after Segmental RefractiveMultifocal Intraocular Lens Implantation |
Zhibo Lin,Fang Huang,Anpeng Pan,Ying Li,Sisi Zhou,Qinmei Wang,Ayong Yu |
Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China |
|
|
Abstract Objective: To investigate the objective and subjective visual quality after a segmental refractive multifocal intraocular lens (IOL) implantation. Methods: This prospective study enrolled cataract patients who underwent phacoemulsification and IOL implantation at our hospital between December 2015 and March
2016. The patients were divided into two groups (each with 14 patients, 22 eyes) based on the IOL type: segmental refractive multifocal IOL (MF30, Oculentis, Holland) as the trial group, and single focal IOL(SN60WF, Alcon, USA) as the control group. Three months after surgery, the spherical equivalent (SE) was measured, and the best-corrected distance visual acuity (BCDVA=5-LogMAR), best-corrected intermediate visual acuity (BCIVA=5-LogMAR), best-corrected near visual acuity (BCNVA=5-LogMAR), and defocus curve were recorded. A double-pass optical quality analysis system (OQAS II, VISIOMETRICS, Spain) was used to
measure the modulation transfer function (MTF), objective scatter index (OSI), Strehl Ratio (SR), and contrast visual acuity. The near spectacle independence, satisfaction, and symptoms of visual disturbance were assessed by a questionnaire. Data were analyzed using independent t test and chi-square test. Results: Three months after surgery, the SE in the trial and control groups were 0.23±0.30 diopter (D) and 0.09±0.51D, respectively (t=1.051, P=0.300); BCDVA was 5.00±0.05 and 4.99±0.03, respectively (t=0.516, P=0.608); BCIVA was 4.83±0.07 and 4.65±0.11, respectively (t=6.610, P<0.001); BCNVA was 4.88±0.04 and 4.51±0.12, respectively (t=14.485, P<0.001); MTF cutoff was 25.23±12.26 and 32.56±8.06 cpd, respectively (t=2.249, P=0.030); OSI was 2.38±0.67 and 1.64±0.84, respectively (t= 3.234, P=0.020). There were no statistical differences between the groups for SR or contrast visual acuity. The defocus curve was smooth within −3.0 D and +1.0 D in the trial group, while only one peak appeared between −0.5 D and +0.5 D in the control group. Near spectacle independence was 91% in the trial group and 12% in the control group (χ2=21.316, P<0.001). Satisfaction was 80% (16/20) and 59% (10/17), respectively (χ2=1.089, P=0.279); Halo/glare was 9% (2/22) and 0% (0/17),respectively (χ2=0.296, P=0.495). Conclusions: The visual quality of the segmental refractive multifocal IOL was clinically acceptable as it offers a full range of visual acuity with few symptoms of visual disturbance.
|
Received: 08 June 2017
|
Corresponding Authors:
Ayong Yu, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China(Email: yaybetter@hotmail.com)
|
|
|
|
[1] |
Ramón ML, Piñero DP, Pérez-Cambrodí RJ. Correlation of visual performance with quality of life and intraocular aberrometric profile in patients implanted with rotationally asymmetric multifocal IOLs. J Refract Surg, 2012, 28(2): 93-99.DOI: 10.3928/1081597X-20111213-02.
|
[2] |
俞阿勇, 施恩, 王勤美, 等. 不同年龄段成年人眼的综合光学质量客观评估. 中华眼科杂志, 2016, 52(1): 47-50. DOI: 10.3760/cma.j.issn.0412-4081.2016.01.012.
|
[3] |
Pan AP, Wang QM, Huang F, et al. Correlation among lens opacities classification system III grading, visual function index-14, pentacam nucleus staging, and objective scatter index for cataract assessment. Am J Ophthalmol, 2015, 159(2): 241-247.e2. DOI: 10.1016/j.ajo.2014.10.025.
|
[4] |
Yu AY, Lu T, Pan AP, et al. Assessment of tear film optical quality dynamics. Invest Ophthalmol Vis Sci, 2016, 57(8):3821-3827. DOI: 10.1167/iovs.15-18985.
|
[5] |
Ramji H, Moore J, Moore CB, et al. Can the accuracy of multifocal intraocular lens power calculation be improved to make patients spectacle free? Cont Lens Anterior Eye, 2016, 39(2):160-166. DOI: 10.1016/j.clae.2015.10.005.
|
[6] |
Venter JA, Pelouskova M, Collins BM, et al. Visual outcomes and patient satisfaction in 9 366 eyes using a refractive segmented multifocal intraocular lens. J Cataract Refract Surg, 2013, 39(10): 1477-1484. DOI: 10.1016/j.jcrs.2013.03.035.
|
[7] |
Chen T, Yu F, Lin H, et al. Objective and subjective visual quality after implantation of all optic zone diffractive multifocal intraocular lenses: a prospective, case-control observational
|
|
study. Br J Ophthalmol, 2016, 100(11): 1530-1535. DOI: 10.1136/bjophthalmol-2015-307135.
|
[8] |
Palomino BC, Carmona GD, Castillo GA, et a1. Evolution of visual perfor- mance in 250 eyes implanted with the Tecnis ZM900 multifocal IOL. European Ophthalmol, 2009, 19(5):
|
76 |
2-768.
|
[9] |
Sedgewick JH, Orillac R, Link C. Array multifocal intraocular lens in a charity hospital training program: a resident's experience. J Cataract Refract Surg, 2002, 28(7): 1205-1210.
|
[10] |
Martínez PA, Gómez FP, España AA, et al. Visual function with bilateral implantation of monofocal and multifocal intraocular lenses: a prospective, randomized, controlled clinical trial. J Refract Surg, 2008, 24(3): 257-264.
|
[11] |
Cochener B, Lafuma A, Khoshnood B, et al. Comparison of outcomes with multifocal intraocular lenses: a meta-analysis. Clin Ophthalmol, 2011, 5: 45-56. DOI:10.2147/OPTH.S14325.
|
[12] |
Pieh S, Kellner C, Hanselmayer G, et al. Comparison of visual acuities at different distances and defocus curves. J Cataract Refract Surg, 2002, 28(11): 1964-1967.
|
[13] |
Alió JL, Piñero DP, Plaza-Puche AB, et al. Visual outcomes and optical performance of a monofocal intraocular lens and a newgeneration multifocal intraocular lens. J Cataract Refract Surg,2011, 37(2): 241-250. DOI: 10.1016/j.jcrs.2010.08.043.
|
[14] |
Muñoz G, Albarrán-Diego C, Ferrer-Blasco T, et al. Visual function after bilateral implantation of a new zonal refractive aspheric multifocal intraocular lens. J Cataract Refract Surg,
|
20 |
11, 37 (11): 2043-2052. DOI: 10.1016/j.jcrs.2011.05.045.
|
[15] |
Packer M, Chu YR, Waltz KL, et al. Evaluation of the aspheric tecnis multifocal intraocular lens: one-year results from the first cohort of the food and drug administration clinical trial. Am J Ophthalmol, 2010, 149(4): 577-584.e1. DOI: 10.1016/j.ajo.2009.10.022.
|
|
|
|